Crystalvue Medical Corporation (TPEX:6527)

Market Cap	1.89B -14.6%
Revenue (ttm)	874.21M -6.8%
Net Income	148.53M +7.5%
EPS	5.75 +6.9%
Shares Out	25.34M
PE Ratio	12.99
Forward PE	n/a
Dividend	2.90 (3.87%)
Ex-Dividend Date	Jul 21, 2026

Volume	10,060
Open	74.70
Previous Close	75.00
Day's Range	74.60 - 74.90
52-Week Range	66.30 - 90.80
Beta	0.70
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2026

About Crystalvue Medical

Crystalvue Medical Corporation manufactures and sells medical devices worldwide. The company offers optical coherence tomography, retinal cameras, tonometers, lens edgers, and gastroenterology supplies, as well as ODM/OEM services for automated nucleic acid extraction instrument and PCR system. It also sells minimal invasive endoscopic instrument supplies. The company was founded in 2009 and is based in Taoyuan City, Taiwan.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2009
• Employees: 109
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6527

Financial Performance

In 2025, Crystalvue Medical's revenue was 949.05 million, an increase of 9.33% compared to the previous year's 868.03 million. Earnings were 146.98 million, an increase of 15.59%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 19, 2026

Data Sources Report a data error